Sample size for K 2 × 2 tables in equivalence studies using Cochran's statistic

Controlled Clinical Trials

Volumn 24, Issue 4, 2003, Pages 378-389

  Song, James X ^a,c   Wassell, James T ^b  

^a BAYER CORPORATION   (United States)

^b NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^c NONE   (United States)

Author keywords

Anti infective; Ciprofloxacin; Cochran's statistics; Equivalence study; Intracluster correlation coefficient; Multicenter trial; Sample size

Indexed keywords

ANALYSIS OF VARIANCE; ARTICLE; BINOMIAL DISTRIBUTION; CLUSTER ANALYSIS; CORRELATION ANALYSIS; INTERMETHOD COMPARISON; MULTICENTER STUDY; SAMPLE SIZE; SIMULATION; STRATIFICATION;

EID: 0037629215     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-2456(03)00026-6     Document Type: Article

References (32)

1. Guidance for industry: developing antimicrobial drugs-general considerations for clinical trials. 1998;Food and Drug Administration Center for Drug Evaluation and Research, Rockville, Maryland.
2. Nabholtz J.M., Buzdar A., Pollak M., et al. Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomized trial. J Clin Oncol. 18:2000;3758-3767.
3. Wit R.D., Roberts J.T., Wilkinson P.M., et al. Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European organization for research and treatment of. J Clin Oncol. 19:2001;1619-1640.
4. Iravani A., Klimberg I., Briefer C., et al. A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection. J Antimicrob Chemother. 43:(Suppl A):1999;67-75.
5. McCarty J.M., Richard G., Huck W., et al. A randomized trial of short-course ciprofloxacin, ofloxacin or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Am J Med. 106:1999;292-299.
6. Ebbutt A.F., Frith L. Practical issues in equivalence trials. Stat Med. 17:1998;1691-1701.
7. Rõhmel J. Therapeutic equivalence investigations: statistical considerations. Stat Med. 17:1997;1703-1714.
8. Lui K.J., Cumberland W.G. Sample size determination for equivalence test using rate ratio of sensitivity and specificity in paired sample size. Control Clin Trials. 22:2001;373-389.
9. Blackwelder W.C. Showing a treatment is good because it is not bad: when does "noninferiority" imply effectiveness? Control Clin Trials. 23:2002;52-54.
10. 2 tests. Biometrics. 10:1954;417-451.
11. Munoz A., Rosner B. Power and sample size for a collection of 2×2 tables. Biometrics. 40:1984;995-1004.
12. Woolson R.F., Bean J.A., Rojas B.P. Sample size for case-control studies using Cochran's statistic. Biometrics. 42:1986;927-932.
13. Wittes J., Wallenstein S. The power of the Mantel-Haenszel test. JASA. 82:1987;1104-1109.
14. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Nat Cancer Inst. 22:1959;719-748.
15. Blackwelder W.C. "Proving the Null Hypothesis" in clinical trials. Control Clin Trials. 3:1982;345-353.
16. Farrington C.P., Manning G. Test statistics and sample size formulae for comparative binomial trials with null hypothesis on non-zero risk difference or non-unity relative risk. Stat Med. 9:1990;1447-1454.
17. Nam J.M. Sample size determination in stratified trials to establish the equivalence of two treatments. Stat Med. 14:1995;2037-2049.
18. Hendricks S.A., Wassell J.T., Collins J.W., Sedlak S.L. Power determination for geographically clustered data using generalized estimating equations. Stat Med. 15:1996;1951-1960.
19. Koch G.G., Carr G.J., Amara I.A., Stokes M.E., Uryniak T.J. Categorical data analysis. Berry D.A. Statistical methodology in the pharmaceutical science. 1990;Marcel Dekker Inc, New York.
20. Haverstock D. Center size effect in the current antimicrobial trial. Unpublished Presentation. July, 2001.
21. Wiens B.L. Choosing an equivalence limit for noninferiority or equivalence studies. Control Clin Trials. 23:2002;2-14.
22. Miettinen O., Nurminen M. Comparative analysis of two rates. Stat Med. 4:1985;213-226.
23. Gart J.J., Nam J. Approximate interval estimation of the difference in binomial parameters: correction for skewness and extension to multiple tables. Biometrics. 46:1990;637-643.
24. Song J.X., Chul A. Cluster randomization trials: a simulation study. Biometrical Journal. 44:2002;375-390.
25. Song J.X., Chul W.A. An evaluation of methods for the stratified analysis of clustered binary data in community intervention trials. Stat Med. 13:2003;2205-2216.
26. Prentice R.L. Correlated binary regression with covariates specific to each binary observation. Biometrics. 44:1988;1033-1048.
27. Koch G.G., Davis S.M., Anderson R.L. Methodological advances and plans for improving regulatory success for confirmatory studies. Stat Med. 17:1998;1675-1690.
28. Choi S.C., Germanson T.P. A simple measure in defining optimal strata in clinical trials. Control Clin Trials. 16:1995;164-171.
29. Donald A., Donner A.A. Adjustments to the Mantel-Haenszel chi-sqare statistic and odds ratio variance estimator when the data are clustered. Stat Med. 6:1987;491-499.
30. Feng Z.D., Grizzle J.E. Correlated binomial variates: properties of estimator of intraclass correlation and its effect on sample size calculation. Stat Med. 11:1992;1607-1614.
31. Radhakrishna S. Combination of results from several 2×2 contingency tables. Biometrics. 21:1965;86-98.
32. Donner A. Sample size requirements for stratified cluster randomization designs. Stat Med. 11:1992;743-750.